Federal contractor · public award history
COHERUS ONCOLOGY, INC.
Parent: COHERUS ONCOLOGY, INC. V13JDMAMELK8
- Awards we know about
- 3
- Typical size
- $11.81M
- Middle of their public awards
- Dollars on those awards
- $11.81M
Most of their awards we can see fall roughly between $11.81M and $11.81M.
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Apr 21, 2027
- Activation date
- May 1, 2026
- Primary NAICS (SAM)
- 325412
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (2)
- Department of Health and Human Services (1)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Health and Human Services$11.81M
PEGFILGRASTIM 6MG/.06ML (INJ, SOLN, SYR OR AUTOINJECTOR) AND VMI
- Department of Veterans Affairs—
NEW AWARD FOR PEGFILGRASTIM WITH COHERUS BIOSCIENCES, INC. ORDERING PERIOD IS APRIL 11, 2025, TO APRIL 10, 2026, WITH FOUR ONE-YEAR OPTIONS.
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.